Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer.
Saved in:
| Title: | Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer. |
|---|---|
| Authors: | Wu, Y.1, Amonkar, M. M.2, Sherrill, B. H.1, O’Shaughnessy, J.3, Ellis, C.2, Baselga, J.4, Blackwell, K. L.5, Burstein, H. J.6 |
| Source: | Annals of Oncology. Dec2011, Vol. 22 Issue 12, p2582-2590. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdr014 |
